- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
OneOncology Announces 3 New Appointments to Executive Leadership Team
OneOncology has announced 3 new appointments to its executive team, bringing in experience to clinical, technological, and financial operations.
OneOncology has announced 3 new appointments to its executive team, bringing in experience to clinical, technological, and financial operations. Natalie Dickson, MD, chief medical officer of Tennessee Oncology, has been appointed as chairperson of OneCouncil, the group's clinical advisory and governance board.
"One of the most important attributes to OneOncology's success is physician collboration at a time of an immense knowledge explosion in oncology," said Dickson. "As the Chair of OneCouncil, I'm looking forward to creating a platform and culture for all our physician partners to contribute to, and utilize the success of, the best clinical practices of the best oncology practices in the country."
Reporting directly to the chief exeuctive officer, Garrick Bernstein has been appointed as the chief financial officer of OneOncology. David Stewart has been appointed to chief information officer of the company and will be responsible for defining adn delivering information technology strategy and capabilities across the OneOncology and its partners.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
